Under proposed new legislation, the U.S. Food and Drug Administration would gain greater authority over pharmacies that compound sterile drugs for tailored use and ship them across state lines.
http://www.reuters.com/article/2013/04/26/meningitis-legislation-idUSL2N0DD1T920130426?feedType=RSS&feedName=rbssHealthcareNews
http://www.reuters.com/article/2013/04/26/meningitis-legislation-idUSL2N0DD1T920130426?feedType=RSS&feedName=rbssHealthcareNews
No comments:
Post a Comment